Clinical importance of thrombocytopenia in patients with acute coronary syndromes: a systematic review and meta-analysis

Clinical importance of thrombocytopenia in patients with acute coronary syndromes: a systematic review and meta-analysis

Thrombocytopenia (TP) is common in hospitalized patients. In the context of acute coronary syndromes (ACS), TP has been linked to adverse clinical outcomes. We present a systematic review and meta-analysis of the evidence on the clinical importance of preexisting and in-hospital acquired TP in the c...

Full description

Bibliographic Details
Main Authors:	Vanessa Discepola, Mireille E. Schnitzer, E. Marc Jolicoeur, Guy Rousseau, Marie Lordkipanidzé
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-10-01
Series:	Platelets
Subjects:	acute coronary syndrome bleeding ischemia major adverse cardiac events mortality thrombocytopenia
Online Access:	http://dx.doi.org/10.1080/09537104.2018.1528348

Similar Items

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study
by: Xiaoping Peng, et al.
Published: (2022-06-01)

Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting
by: Wail Nammas, et al.
Published: (2019-05-01)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
by: So Ikebe, et al.
Published: (2023-09-01)

Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials
by: Zhenhua Xing, et al.
Published: (2018-08-01)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
by: Marjo Okkonen, et al.
Published: (2021-01-01)

Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes
by: Shashank Murali, et al.
Published: (2020-05-01)

Short-term Outcomes and Mid-term Follow-up After Coronary Angioplasty in Patients Younger Than 40 Years of Age
by: Hamidreza Poorhosseini, et al.
Published: (2007-07-01)

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study
by: Jiannan Li, et al.
Published: (2020-08-01)

The 2017 International Joint Working Group recommendations of the Indian College of Cardiology, the Academic College of Emergency Experts, and INDUSEM on the management of low-risk chest pain in emergency departments across India
by: Vivek Chauhan, et al.
Published: (2017-01-01)

Predictors of major adverse cardiac and cerebrovascular events after percutaneous coronary intervention in older adults: a systematic review and meta-analysis
by: Arash Jalali, et al.
Published: (2024-04-01)

The prognostic study of mental stress-induced myocardial ischemia in coronary revascularization patients with depression/anxiety: rationale and design
by: Nan Nan, et al.
Published: (2023-05-01)

The value of neutrophil-to-lymphocyte ratio in predicting severity of coronary involvement and long-term outcome of percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis
by: Farzad Shahsanaei, et al.
Published: (2024-03-01)

The latest cutoff value of high-sensitivity cardiac troponin I (access hs-TnI) for major adverse cardiac events during the perioperative period of coronary artery bypass grafting: a retrospective study from a single heart center
by: Li Shan-shan, et al.
Published: (2022-06-01)

ETV6-related thrombocytopenia and platelet dysfunction
by: Jorge Di Paola, et al.
Published: (2021-01-01)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
by: Loredana Bury, et al.
Published: (2021-02-01)

Impact of Hyperinsulinemia on Long-Term Clinical Outcomes of Percutaneous Coronary Intervention in Patients without Diabetes Who Have Acute Myocardial Syndrome
by: Tan Q, et al.
Published: (2021-09-01)

Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia
by: Min Xu, et al.
Published: (2020-08-01)

Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial
by: Ying Pan, et al.
Published: (2023-12-01)

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study
by: Haijun Zheng, et al.
Published: (2022-06-01)

The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States
by: Jaime Shaw, et al.
Published: (2020-04-01)

Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome
by: Fangmeng Lei, et al.
Published: (2022-07-01)

Predictive significance and diagnostic accuracy of plasma fibrinogen levels for coronary stenting outcomes
by: Tarun Bansal, et al.
Published: (2022-12-01)

Angiographic Profile of Type 2 Diabetic Patients with ST Elevation Myocardial Infarction: A Cross-sectional Study
by: Anand Koppad, et al.
Published: (2022-10-01)

Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease
by: Yuan Lin, et al.
Published: (2023-10-01)

Association of haemoglobin glycation index with outcomes in patients with acute coronary syndrome: results from an observational cohort study in China
by: Jiayu Li, et al.
Published: (2022-10-01)

Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial
by: Yayun Cui, et al.
Published: (2022-09-01)

Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
by: Dorela Lame, et al.
Published: (2024-03-01)

Inherited thrombocytopenias—recent advances in clinical and molecular aspects
by: Carlo L. Balduini, et al.
Published: (2017-01-01)

Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Tommaso Bucci, et al.
Published: (2024-03-01)

Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia
by: Yun Zhang, et al.
Published: (2023-12-01)

Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
by: Roser Calvo
Published: (2019-04-01)

Artificial Intelligence of Arterial Doppler Waveforms to Predict Major Adverse Outcomes Among Patients Evaluated for Peripheral Artery Disease
by: Robert D. McBane, et al.
Published: (2024-02-01)

7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country
by: Parmida Sadat Pezeshki, et al.
Published: (2023-05-01)

Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis
by: Emily Sirotich, et al.
Published: (2024-01-01)

Diabetic kidney disease as an independent predictor of long-term adverse outcomes in patients with coronary artery disease and diabetic mellitus
by: Zhiyu Liu, et al.
Published: (2024-03-01)

Early and mid-term outcomes of off-pump versus on-pump coronary artery bypass surgery in patients with triple-vessel coronary artery disease: a randomized controlled trial
by: Seyed Mohammad Forouzannia, et al.
Published: (2023-04-01)

Assessment of clinical spectrum of thrombocytopenia and its association with different disease states reported in Dow Diagnostic Reference and Research Lab (DDRRL)
by: Farah Fatima Abbas, et al.
Published: (2023-11-01)

Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial
by: Hye Rim Na, et al.
Published: (2022-05-01)

Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease
by: Zhao L, et al.
Published: (2023-09-01)

Hyperlipidemia in immune thrombocytopenia: a retrospective study
by: Shouqing Han, et al.
Published: (2023-10-01)